Drugs
-
?
-
FDA Drug Safety Podcasts
The FDA Drug Safety Podcasts are produced by FDA's Center for Drug Evaluation and Research (CDER). They provide emerging safety information about drugs in conjunction with the release of Public Health Advisories and other drug safety issues.
Latest Drug Safety Podcasts
Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem | January 11, 2013 | Run Time: 00:06:15 | Transcript | |
Serious skin reactions after combination treatment with the Hepatitis C drugs Incivek (telaprevir), peginterferon alfa, and ribavirin | December 26, 2012 | Run Time: 00:05:46 | Transcript | |
Warning against use of Xyrem (sodium oxybate) with alcohol or drugs causing respiratory depression | December 21, 2012 | Run Time: 00:04:53 | Transcript | |
Pradaxa (dabigatran etexilate mesylate) should not be used in patients with mechanical prosthetic heart valves | December 21, 2012 | Run Time: 00:03:58 | Transcript | |
Safety review update of Chantix (varenicline) and risk of cardiovascular adverse events | December 13, 2012 | Run Time: 00:04:19 | Transcript | |
Important change to heparin container labels to clearly state the total drug strength | December 7, 2012 | Run Time: 00:03:56 | Transcript | |
Updated information on 32 mg intravenous ondansetron (Zofran) dose and pre-mixed ondansetron products | December 6, 2012 | Run Time: 00:03:43 | Transcript | |
Investigation into New England Compounding Center | November 13, 2012 | Run Time: 00:03:00 | Transcript | |
Ameridose | November 13, 2012 | Run Time: 00:02:00 | Transcript | |
Update on the risk for serious bleeding events with the anticoagulant Pradaxa | November 2, 2012 | Run Time: 00:05:30 | Transcript | |
Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays | October 25, 2012 | Run Time: 00:04:01 | Transcript | |
Ongoing safety review of Parkinson’s drug Mirapex (pramipexole) and possible risk of heart failure | September 21, 2012 | Run Time: 00:03:06 | Transcript | |
Rare cases of serious burns with the use of over-the-counter topical muscle and joint pain relievers | September 13, 2012 | Run Time: 00:03:46 | Transcript | |
FDA recommends against use of Revatio in children with pulmonary hypertension | August 30, 2012 | Run Time: 00:03:06 | Transcript | |
Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death | August 15, 2012 | Run Time: 00:04:22 | Transcript | |
Seizure risk for multiple sclerosis patients who take Ampyra (dalfampridine) | July 23, 2012 | Run Time: 00:04:29 | Transcript | |
New information regarding QT prolongation with ondansertron (Zofran) | July 5, 2012 | Run Time: 00:04:34 | Transcript | |
Cefepime and risk of seizure in patients not receiving dosage adjustments for kidney impairment | June 26, 2012 | Run Time: 00:03:17 | Transcript | |
FDA advises healthcare providers to visually inspect Hospira Carpuject pre-filled cartridges for overfill | May 23, 2012 | Run Time: 00:03:14 | Transcript | |
Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod) | May 14, 2012 | Run Time: 00:03:47 | Transcript | |
Safety review update of cancer drug Revlimid (lenalidomide) and risk of developing new types of malignancies | May 7, 2012 | Run Time: 00:03:02 | Transcript | |
Updated information on drug interactions between Victrelis (boceprevir) and certain boosted HIV protease inhibitor drugs | April 26, 2012 | Run Time: 00:03:55 | Transcript | |
New Warning and Contraindication for blood pressure medicines containing aliskiren (Tekturna) | April 20, 2012 | Run Time: 00:03:45 | Transcript | |
Updated information about the risk of blood clots in women taking birth control pills containing drospirenone | April 11, 2012 | Run Time: 00:03:04 | Transcript | |
Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses | March 30, 2012 | Run Time: 00:05:29 | Transcript | |
Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury | March 2, 2012 | Run Time: 00:02:22 | Transcript | |
Important safety label changes to cholesterol-lowering statin drugs | March 2, 2012 | Run Time: 00:03:37 | Transcript | |
Important drug interactions between Victrelis (boceprevir) and ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitor drugs | February 10, 2012 | Transcript | ||
Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs) | February 8, 2012 | Transcript | ||
New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab) | January 20, 2012 | Transcript | ||
New Boxed Warning and Contraindication for Adcetris (brentuximab vedotin) | January 13, 2012 | Transcript | ||
Update - Preliminary findings from ongoing investigations of CardioGen-82 | January 13, 2012 | Transcript |
-
-